Advertisement
Screener

PLIANT THERAPEUTICS, INC. (PLRX) Company Profile

2.8 / 5 stars · 68/120 Roast Me

Available history
No dated observations
Data captured

IPO Date coverage

PLRX IPO Date summary

PLIANT THERAPEUTICS, INC. (PLRX). What the retained company guidance contains and how many periods can be scored.

  • Legal name: Value PLIANT THERAPEUTICS, INC..
  • Ticker: Value PLRX.
  • Exchange: Value Nasdaq.
  • IPO date: Value 3 Jun 2020.
MeasureValue
Legal namePLIANT THERAPEUTICS, INC.
TickerPLRX
ExchangeNasdaq
IPO date3 Jun 2020
CountryUnited States
Final IPO prospectusForm 424B4 filed 2020-06-03, accession 0001193125-20-159718
Registration statementForm S-1 filed 2020-05-11, accession 0001193125-20-137876

Similar stocks

Stock NameCountryMarket CapPE Ratio
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Cingulate Inc. (CING)United States$0.073B-2.64
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
XBiotech Inc. (XBIT)United States$0.066B-1.56
OS Therapies Inc (OSTX)United States$0.076B-2.17